Leger; Roger
Patent Applications and Registrations
Patent applications and USPTO patent grants for Leger; Roger.The latest application filed is for "compositions and methods for the treatment of cast nephropathy and related conditions".
- Leger; Roger - Saint-Lambert CA
- Leger; Roger - St-Lambert CA
- Leger, Roger - Quebec CA
- Leger; Roger - Mountain View CA
| Patent | Date |
|---|---|
| Compositions And Methods For The Treatment Of Cast Nephropathy And Related Conditions App 20180057534 - Leger; Roger ; et al. | 2018-03-01 |
| Compositions and methods for the treatment of cast nephropathy and related conditions Grant 9,611,297 - Leger , et al. April 4, 2 | 2017-04-04 |
| Peptides With Enhanced Stability And Their Use In Methods For Treating Diseases App 20160137714 - KECK; Peter C. ; et al. | 2016-05-19 |
| Anti-obesity agents Grant 7,906,482 - Bridon , et al. March 15, 2 | 2011-03-15 |
| Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders Grant 7,737,251 - Bridon , et al. June 15, 2 | 2010-06-15 |
| Long Lasting Glucagon-like Peptide 2 (glp-2) For The Treatment Of Gastrointestinal Diseases And Disorders App 20090312259 - Bridon; Dominique P. ; et al. | 2009-12-17 |
| Long Lasting Natriuretic Peptide Derivatives App 20090275506 - BAKIS; Peter ; et al. | 2009-11-05 |
| Anti-obesity agents Grant 7,601,691 - Bridon , et al. October 13, 2 | 2009-10-13 |
| Long Lasting Natriuretic Peptide Derivatives App 20080199532 - Bakis; Peter ; et al. | 2008-08-21 |
| Novel Anti-Obesity Agents App 20080194486 - Bridon; Dominique P. ; et al. | 2008-08-14 |
| Halogenated Quinazolinyl Nitrofurans As Antibacterial Agents App 20080146562 - Chamberland; Suzanne ; et al. | 2008-06-19 |
| Long lasting growth hormone releasing factor derivatives Grant 7,268,113 - Bridon , et al. September 11, 2 | 2007-09-11 |
| Long lasting insulin derivatives and methods thereof App 20060241019 - Bridon; Dominique P. ; et al. | 2006-10-26 |
| Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders App 20060217304 - Bridon; Dominique P. ; et al. | 2006-09-28 |
| Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders Grant 7,112,567 - Bridon , et al. September 26, 2 | 2006-09-26 |
| Long lasting natriuretic peptide derivatives App 20050176641 - Bakis, Peter ; et al. | 2005-08-11 |
| Anti-obesity agents App 20050176643 - Bridon, Dominique P. ; et al. | 2005-08-11 |
| Long lasting natriuretic peptide derivatives App 20040266673 - Bakis, Peter ; et al. | 2004-12-30 |
| Long lasting glucagon-like peptide2(glp-2)for the treatment of gastrointestinal diseases and disorders App 20040248782 - Bridon, Dominique P. ; et al. | 2004-12-09 |
| Long lasting growth hormone releasing factor derivatives App 20030073630 - Bridon, Dominique P. ; et al. | 2003-04-17 |
| Hydrolytic enzyme substrates and assay method Grant 6,455,268 - Jarnigan , et al. September 24, 2 | 2002-09-24 |
| Peptidomimetic efflux pump inhibitors Grant 6,436,980 - Leger , et al. August 20, 2 | 2002-08-20 |
| Efflux pump inhibitors Grant 6,399,629 - Chamberland , et al. June 4, 2 | 2002-06-04 |
| Efflux pump inhibitors Grant 6,245,746 - Chamberland , et al. June 12, 2 | 2001-06-12 |
| Peptidomimetic efflux pump inhibitors Grant 6,204,279 - Leger , et al. March 20, 2 | 2001-03-20 |
| Efflux pump inhibitors Grant 6,114,310 - Chamberland , et al. September 5, 2 | 2000-09-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 